| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analysis of four hereditary protein C deficiencies associated with vascular thromboembolism
|
Chen, Xuanyu
|
|
|
103 |
6 |
p. 2145-2155
|
article
|
| 2 |
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia
|
Yang, Liyan
|
|
|
103 |
6 |
p. 1877-1885
|
article
|
| 3 |
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis
|
Chen, Chih-Cheng
|
|
|
103 |
6 |
p. 1947-1965
|
article
|
| 4 |
Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture
|
Shimozawa, Katsuyoshi
|
|
|
103 |
6 |
p. 2161-2162
|
article
|
| 5 |
Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers
|
Ebrahimi, Rasoul
|
|
|
103 |
6 |
p. 1819-1831
|
article
|
| 6 |
Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT
|
Shao, Wenwei
|
|
|
103 |
6 |
p. 2089-2102
|
article
|
| 7 |
Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients
|
Kim, Bo Kyung
|
|
|
103 |
6 |
p. 2051-2058
|
article
|
| 8 |
Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes
|
Zhang, Zhuxin
|
|
|
103 |
6 |
p. 1897-1907
|
article
|
| 9 |
Could it be VEXAS?
|
Guerineau, Hippolyte
|
|
|
103 |
6 |
p. 2169-2171
|
article
|
| 10 |
CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia
|
Alayoubi, Abdulfatah M.
|
|
|
103 |
6 |
p. 1805-1817
|
article
|
| 11 |
Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia
|
Palani, Hamenth Kumar
|
|
|
103 |
6 |
p. 2181-2183
|
article
|
| 12 |
Diagnosing aceruloplasminemia: navigating through red herrings
|
Kharel, Zeni
|
|
|
103 |
6 |
p. 2173-2176
|
article
|
| 13 |
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China
|
Luo, Lan
|
|
|
103 |
6 |
p. 2073-2087
|
article
|
| 14 |
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies
|
Reimann, Patrick
|
|
|
103 |
6 |
p. 2123-2131
|
article
|
| 15 |
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel
|
Kanter, Julie
|
|
|
103 |
6 |
p. 1909-1917
|
article
|
| 16 |
GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy
|
Liu, Yanfeng
|
|
|
103 |
6 |
p. 1967-1977
|
article
|
| 17 |
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab
|
Qing, Min
|
|
|
103 |
6 |
p. 1989-2001
|
article
|
| 18 |
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia
|
Meloni, Antonella
|
|
|
103 |
6 |
p. 1887-1896
|
article
|
| 19 |
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML
|
Jain, Akriti G
|
|
|
103 |
6 |
p. 1941-1945
|
article
|
| 20 |
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia
|
Jebanesan, Daniel Zechariah Paul
|
|
|
103 |
6 |
p. 1919-1929
|
article
|
| 21 |
Letter to Editor: Treatment with the apoptosis inhibitor asunercept reduces clone sizes in patients with lower risk myelodysplastic neoplasms
|
Zaidi, Syeda Dua e Zehra
|
|
|
103 |
6 |
p. 2163-2164
|
article
|
| 22 |
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study
|
Schwaner, Ingo
|
|
|
103 |
6 |
p. 2013-2020
|
article
|
| 23 |
Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study
|
Li, Wenqi
|
|
|
103 |
6 |
p. 2003-2012
|
article
|
| 24 |
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma
|
Fujii, Keiichiro
|
|
|
103 |
6 |
p. 2041-2050
|
article
|
| 25 |
Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia
|
Perruso, Luiza Lapolla
|
|
|
103 |
6 |
p. 2033-2039
|
article
|
| 26 |
Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial
|
Anand, Aishwarya
|
|
|
103 |
6 |
p. 2133-2144
|
article
|
| 27 |
1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study
|
Gao, Shuang
|
|
|
103 |
6 |
p. 1979-1987
|
article
|
| 28 |
Quality of life after immune suppressive therapy in aplastic anemia
|
Lommerse, Iris N.
|
|
|
103 |
6 |
p. 2113-2121
|
article
|
| 29 |
Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia
|
Wang, Xiangyu
|
|
|
103 |
6 |
p. 1843-1857
|
article
|
| 30 |
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study
|
Palandri, F.
|
|
|
103 |
6 |
p. 1931-1940
|
article
|
| 31 |
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601
|
Shimada, Kazuyuki
|
|
|
103 |
6 |
p. 2021-2031
|
article
|
| 32 |
Systematic analysis of copper, zinc, and selenium levels in JAK2 V617F-positive myeloproliferative neoplasms
|
Shivarov, Velizar
|
|
|
103 |
6 |
p. 2177-2179
|
article
|
| 33 |
Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia
|
Tazoe, Kumiyo
|
|
|
103 |
6 |
p. 2059-2072
|
article
|
| 34 |
Therapeutic progress in relapsed/refractory multiple myeloma
|
Chen, Qi
|
|
|
103 |
6 |
p. 1833-1841
|
article
|
| 35 |
Thiotepa-busulfan-fludarabine-based conditioning as a promising approach prior to allogeneic hematopoietic stem cell transplantation in patients with blastic plasmacytoid dendritic cell neoplasm
|
Huang, Xianbo
|
|
|
103 |
6 |
p. 2165-2168
|
article
|
| 36 |
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis
|
Lucijanic, Marko
|
|
|
103 |
6 |
p. 2157-2159
|
article
|
| 37 |
Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series
|
Hu, Mengze
|
|
|
103 |
6 |
p. 2103-2111
|
article
|
| 38 |
Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects
|
Ghafoor, Bushra
|
|
|
103 |
6 |
p. 1859-1876
|
article
|
Journal description